| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.089 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.085 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |